Mefenorex Explained

Mefenorex (Rondimen, Pondinil, Anexate) is a stimulant drug which was used as an appetite suppressant. It is an amphetamine derivative which was developed in the 1970s and used for the treatment of obesity.[1] [2] Mefenorex produces amphetamine as a metabolite,[3] and has been withdrawn in many countries despite having only mild stimulant effects and relatively little abuse potential.[4]

Notes and References

  1. Vincendeau MJ . [A new regulator of appetite: mefenorex] . fr . Bordeaux Medical . 3 . 7 . 1951–3 . 1970 . 5455004 .
  2. Beyer G, Huth K, Müller GM, Niemöller H, Raisp I, Vorberg G . [The treatment of obesity with the appetite curbing agent Mefenorex] . de . Die Medizinische Welt . 31 . 8 . 306–9 . February 1980 . 7374423 .
  3. Rendić S, Slavica M, Medić-Sarić M . 7170057 . Urinary excretion and metabolism of orally administered mefenorex . European Journal of Drug Metabolism and Pharmacokinetics . 19 . 2 . 107–17 . 1994 . 8001591 . 10.1007/BF03188831 .
  4. Engel J, Kristen G, Schaefer A, von Schlichtegroll A . Mefenorex (Rondimen) . Drug and Alcohol Dependence . 17 . 2–3 . 229–34 . June 1986 . 3743406 . 10.1016/0376-8716(86)90010-4 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Mefenorex".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.